We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cytokine Profiles and Personalized Therapeutics in COVID-19 Patients
Webinar

Cytokine Profiles and Personalized Therapeutics in COVID-19 Patients

Cytokine Profiles and Personalized Therapeutics in COVID-19 Patients
Webinar

Cytokine Profiles and Personalized Therapeutics in COVID-19 Patients

Guy Gorochov, MD, Ph.D
Guy Gorochov, MD, Ph.D
Professor of Medicine, Head of the Department of Immunology and Co-Director CIMI Research Centre, Sorbone University/INSERM
Laurel Provencher, PhD
Laurel Provencher, PhD
Senior Director, Strategic Collaborations, Quanterix Corporation

Recent observations by Prof. Gorochov’s team at the CIMI Research Centre suggest that there are at least two distinct types of cytokine signatures induced by SARS-CoV-2 infection. At time of hospitalization, COVID-19 patients with severe respiratory disease present low viremia and a dominant pro-inflammatory response.


In contrast, less severe patients have a high viral load and elevated type-I interferon levels. Nevertheless, a strong antiviral interferon response is not always beneficial. Importantly, the risk of death was associated with the intensity of the cytokine signatures characterizing each severity group. These findings call for a personalized approach to successfully treat COVID-19 patients.


Attend this webinar to:

  • Learn about recently published observations that describe distinct cytokine profiles and COVID-19 severity and mortality
  • Discuss the need for personalized precision medicine approach to successfully treat COVID-19 patients
  • Explore the ultra-sensitive biomarker detection technologies that enabled these findings
Advertisement